Prothrombin index decrease: A useful and reliable marker of extensive fibrosis?

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 10, 2002, Pages 1057-1059

  Cadranel, Jean Francois ^a   Mathurin, Philippe ^a  

^a CENTRE HOSPITALIER LAENNEC   (France)

Author keywords

Cirrhosis; Liver fibrosis; Non invasive serum markers of liver fibrosis; Prothrombin index

Indexed keywords

PROTHROMBIN;

CLINICAL EXAMINATION; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; PREDICTION; PRIORITY JOURNAL; RELIABILITY; SHORT SURVEY; STANDARDIZATION; VIRUS HEPATITIS;

APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; HUMANS; LIVER CIRRHOSIS; PROTHROMBIN; SENSITIVITY AND SPECIFICITY;

EID: 0036793878     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200210000-00004     Document Type: Short Survey

References (16)

1. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32:477-481.
2. Maharaj B, Maharaj RJ, Leary P, Coopan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1:523-525.
3. Torres-Salinas M, Pares A, Caballeria J, Jimenez W, Heredia D, Bruguera M, Rodes J. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic patients. Gastroenterology 1986; 90:1241-1246.
4. Niemelä O, Ristelli L, Sotaniemi EA, Risteli J. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology 1983; 85:254-259.
5. Annoni G, Colombo M, Cantaluppi MC, Bourtos Khlat, Lambertico P, Rojkind M. Serum type III procollagen and laminin (Lam-P1) detect alcoholic hepatitis in chronic alcohol abusers. Hepatology 1989; 9:693-697.
6. Teare JP, Sherman D, Greenfield SM, Simpson J, Bray G, Catteral AP, et al. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet 1993; 342:895-898.
7. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113:1609-1616.
8. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, et al. Noninvasive prediction of severe fibrosis in patients with alcoholic liver fibrosis. Gastroenterol Clin Biol 2000; 24:626-630.
9. Poynard T, Abella A, Pignon JP, Naveau S, Leluc R, Chaput JC. Apolipoprotein Al and alcoholic liver disease. Hepatology 1986; 6:1391-1395.
10. Poynard T, Aubert A, Bedossa P, Abella A, Naveau S, Paraf F, Chaput JC. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991; 100:1397-1402.
11. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis. Dig Dis Sci 1994; 39:2426-2432.
12. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357:1069-1075.
13. Poynard T, Imbert-Bismuth F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002; 9:128-133.
14. Croquet V, Vuillemin E, Ternisien C, Pilette C, Oberti F, Gallois Y, et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol 2002; 14:1133-1141.
15. Cales P, Oberti F, Rousselet MC, Gallois Y, Bedossa P. Usual biochemical tests are not suitable surrogate markers for the degree of liver fibrosis. J Hepatol 2002; 36:199.
16. Winkfield B, Oberti F, Aube C, Vuillemin E, Rousselet MC, Calės P. SNCF: a non invasive score to reduce the false negative rate of liver biopsies for cirrhosis. J Hepatol 2002; 36:200.